Ergomed (LON:ERGO) Shares Pass Above 50-Day Moving Average of $1,035.04

Ergomed plc (LON:ERGO – Get Rating)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1,035.04 ($12.87) and traded as high as GBX 1,088 ($13.53). Ergomed shares last traded at GBX 1,030 ($12.81), with a volume of 50,966 shares changing hands.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Berenberg Bank reissued a “buy” rating and set a GBX 1,450 ($18.03) target price on shares of Ergomed in a research report on Tuesday, March 21st. Numis Securities reaffirmed a “buy” rating and issued a GBX 1,600 ($19.90) target price on shares of Ergomed in a report on Tuesday, February 14th. Finally, Shore Capital reissued a “hold” rating on shares of Ergomed in a research report on Tuesday, March 21st.

Ergomed Stock Down 0.2 %

The firm has a 50 day moving average of GBX 1,035.04 and a 200-day moving average of GBX 1,176.52. The company has a debt-to-equity ratio of 3.43, a current ratio of 1.50 and a quick ratio of 1.22. The stock has a market capitalization of £517.94 million, a P/E ratio of 3,551.72 and a beta of 0.83.

About Ergomed

(Get Rating)

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance.